Credit Suisse’s InflaRx IFRX Stock Holding History

Credit Suisse’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,445	Closed	-$40K	–	4053
2020 Q1	$40K	Buy	+10,445	New	+$38.7K	﹤0.01%	3918
2019 Q3	–	Sell	-40,312	Closed	-$128K	–	4163
2019 Q2	$128K	Buy	+40,312	New	+$1.28M	﹤0.01%	3927

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Credit Suisse's IFRX Position: Q2 2020 in Review

Credit Suisse sold out of InflaRx (IFRX) in Q2 2020, closing a stake of 10,445 shares — an estimated $40K sold.

Credit Suisse first reported a position in IFRX in Q2 2019 and held it in 2 quarters. The position peaked at $128K in Q2 2019. 35 funds tracked by Wall St. Rank hold IFRX as of Q2 2020.

Credit Suisse reported no remaining InflaRx position as of Q2 2020 after selling out during the quarter.
Credit Suisse sold 10,445 InflaRx shares in Q2 2020, an estimated $40K.
Credit Suisse first reported a position in InflaRx in Q2 2019 and held it in 2 quarters.
Credit Suisse's InflaRx position peaked at $128K in Q2 2019.
35 funds tracked by Wall St. Rank held InflaRx as of Q2 2020.

Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.